FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13826711000001101: Almotriptan 12.5mg tablets 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49700801000001116 Almotriptan 12.5mg tablets 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
49700901000001110 Almotriptan 12.5mg tablets 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Almotriptan 12.5mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has VMP Almotriptan 12.5mg tablets false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has VMP Almotriptan 12.5mg tablets true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Is pack of Product containing precisely almotriptan malate 12.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has active ingredient Almotriptan false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has active ingredient Almotriptan hydrogen malate false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has VMP Product containing precisely almotriptan malate 12.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Almotriptan true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has specific active ingredient Almotriptan hydrogen malate true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Almotriptan 12.5mg tablets 12 tablet Has basis of strength substance Almotriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Almogran 12.5mg tablets (Doncaster Pharmaceuticals Ltd) 12 tablet Is a True Almotriptan 12.5mg tablets 12 tablet Inferred relationship Existential restriction modifier
Almogran 12.5mg tablets (Waymade Healthcare Plc) 12 tablet Is a True Almotriptan 12.5mg tablets 12 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start